The Online Investor

Slideshow Mergers & Acquisitions

By The Online Investor Staff, updated Thu., Feb. 27, 2:58 PM

Slide #46. Aytu BioScience, Inc. Innovus Pharmaceuticals, Inc.

Acquirer: Aytu BioScience, Inc. (NASDAQ:AYTU)
Acquiree: Innovus Pharmaceuticals, Inc.
Details: Aytu BioScience, Inc. (NASDAQ:AYTU), a specialty pharmaceutical company focused on commercializing novel products that address significant patient needs and Innovus Pharmaceuticals, Inc., a specialty pharmaceutical company commercializing, licensing and developing safe and effective consumer health products, today announced that the companies have closed the acquisition of Innovus by Aytu. Through this transaction Aytu has retired all outstanding common stock of Innovus and certain Innovus warrants for consideration consisting of approximately 3.8 million shares of Aytu common stock and approximately 2 million shares of preferred stock (convertible on a 1:1 basis into common stock) and the forgiveness of $1.35 million of debt previously owed to Aytu. On a consolidated basis, Aytu will also assume $3.2 million in unsecured debt of Innovus.

Aytu Bioscience is a pharmaceutical company focused on identifying, acquiring, and commercializing products. Co.'s products include: Natesto® (testosterone) nasal gel, which is a testosterone replacement therapy for hypogonadism (low testosterone) in men; Tuzistra® XR, which is a codeine-based antitussive; ZolpiMist™, which is indicated for the short-term treatment of insomnia, and is an oral spray formulation of zolpidem tartrate - prescribed prescription sleep aid in the United States; and MiOXSYS®, which is an in vitro diagnostic system that performs a semen analysis test used to measure static oxidation-reduction potential in human semen, and is marketed outside the United States.

Open the AYTU Page at The Online Investor »

Company Name: 
Aytu BioScience Inc
Drugs & Pharmaceuticals
Number of ETFs Holding AYTU: 
Total Market Value Held by ETFs: 
Total Market Capitalization: 
% of Market Cap. Held by ETFs: 

Open the AYTU Page at The Online Investor (in a new window) »

Quotes delayed 20 minutes

Strong Buy (4.00 out of 4)
98th percentile
(ranked higher than approx. 98% of all stocks covered)
Based on Zacks ABR data;
powered by Xignite

Mergers & Acquisitions Page |

Copyright © 1998 - 2020, All Rights Reserved
Nothing in The Online Investor is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and stock market videos powered by Market News Video. Quote data delayed at least 20 minutes; data powered by Ticker Technologies, and Mergent. Contact The Online Investor; Meet Our Editorial Staff.